Laboratory requisitions for TB-500 (5mg / 10mg) fail QA when specification fields are paraphrased. TB-500 COA and Batch Review Notes maps Repair & Recovery Research catalog data on sulanpeptide.vip.
TB-500 is a synthetic thymosin beta-4 fragment used in laboratory research on actin-binding pathway models, cell-migration assays, extracellular-matrix remodeling, and repair-signaling systems.
TB-500 corresponds to thymosin β4 actin-binding domain sequences promoting actin polymerization and cell migration in corneal and cardiac wound models. Research examines actin filament density by phalloidin staining and lamellipodia dynamics by live-cell imaging after peptide treatment.
Corneal wound healing in rabbit models, cardiac fibroblast migration, and endothelial sprouting assays document TB-500 research applications. Goldstein and colleagues characterized thymosin β4 as the principal actin-sequestering peptide in mammalian cells, underpinning fragment peptide research.
Cross-check CAS 885340-08-9 and purity target ≥ 99.0%; archive approved PDFs with internal sample IDs. Janoshik records for TB-500, when listed at sulanpeptide.vip/coa, should be verified by task number and unique key before sample release.
COA review: Match COA product name, lot, test date, and HPLC purity to vial labels for TB-500.
Catalog identifiers for TB-500: CAS 885340-08-9, Formula: C38H68N10O14. MW 889.0 g/mol, purity target ≥ 99.0%. Copy these fields into requisitions and match them line-by-line on incoming COA PDFs.
Migration and receptor assays for TB-500 are sensitive to degradation—confirm lot purity before release.
Request method details on TB-500 COA if purity is reported without chromatogram context.
Migration and signaling assays using TB-500 are sensitive to oxidized or aggregated peptide. Lot release should include visual inspection (White Lyophilized Powder) plus COA approval—not catalog marketing text alone. COA review for TB-500 starts with identity: product name, lot, and specification (5mg / 10mg) must match the vial label character-for-character. QA teams then confirm CAS 885340-08-9 and purity target ≥ 99.0% against internal release thresholds before material enters cell or animal workflows.
Chromatographic context on TB-500 COA documents matters when purity is near your laboratory cutoff. Request integration traces or method summary if the PDF lists only a numeric HPLC result without column or gradient details. Archive TB-500 COA PDFs using filenames tied to internal sample IDs (for example LAB-2026-0042_COA.pdf). Link reconstitution logs and aliquot records to the same ID chain so audits retrieve documentation in one step.
Janoshik-verified TB-500 batches listed at sulanpeptide.vip/coa add third-party confirmation when task number and unique key validate successfully. Failed verification should trigger quarantine until the supplier clarifies batch status.
Archive TB-500 COA PDFs using filenames tied to internal sample IDs (for example LAB-2026-0042_COA.pdf). Link reconstitution logs and aliquot records to the same ID chain so audits retrieve documentation in one step. Janoshik-verified TB-500 batches listed at sulanpeptide.vip/coa add third-party confirmation when task number and unique key validate successfully. Failed verification should trigger quarantine until the supplier clarifies batch status.
Chromatographic context on TB-500 COA documents matters when purity is near your laboratory cutoff. Request integration traces or method summary if the PDF lists only a numeric HPLC result without column or gradient details.
TB-500 from Sulan Peptide Official is for research use only (RUO)—not for human or veterinary use. Questions: Contact page or WhatsApp on sulanpeptide.vip.